对干细胞公司的回复 - Suppr | 超能文献

Response to StemCells Inc.

作者信息

Monuki Edwin S, Anderson Aileen J, Blurton-Jones Mathew, Cummings Brian J

机构信息

Sue & Bill Gross Stem Cell Research Center, University of California-Irvine, Irvine, CA 92697, USA; Institute for Memory Impairments & Neurological Disorders, University of California-Irvine, Irvine, CA 92697, USA; Department of Pathology & Laboratory Medicine, University of California-Irvine, Irvine, CA 92697, USA.

Sue & Bill Gross Stem Cell Research Center, University of California-Irvine, Irvine, CA 92697, USA; Institute for Memory Impairments & Neurological Disorders, University of California-Irvine, Irvine, CA 92697, USA; Department of Physical & Medical Rehabilitation, University of California-Irvine, Irvine, CA 92697, USA; Department of Anatomy & Neurobiology, University of California-Irvine, Irvine, CA 92697, USA.

出版信息

Stem Cell Reports. 2017 Feb 14;8(2):195-197. doi: 10.1016/j.stemcr.2017.02.002.

DOI:10.1016/j.stemcr.2017.02.002

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5312268/

Abstract

摘要

相似文献

1

Response to StemCells Inc.对干细胞公司的回复

Stem Cell Reports. 2017 Feb 14;8(2):195-197. doi: 10.1016/j.stemcr.2017.02.002.

2

Reaction from StemCells, Inc. to Two Papers in Stem Cell Reports on the Efficacy of Human NSCs in Mouse Models of Alzheimer's Disease and Spinal Cord Injury.干细胞公司对发表于《干细胞报告》上的两篇关于人类神经干细胞在阿尔茨海默病和脊髓损伤小鼠模型中疗效的论文的反应。

Stem Cell Reports. 2017 Feb 14;8(2):194-195. doi: 10.1016/j.stemcr.2017.02.001.

3

Stem cell patents--reexamination/litigation--the last 5 years.干细胞专利——重新审查/诉讼——过去五年

Tissue Eng Part B Rev. 2009 Mar;15(1):87-90. doi: 10.1089/ten.teb.2008.0456.

4

StemCells, Inc.: Clinical trials of stem cell therapies for CNS disorders. Interview with Martin McGlynn.StemCells, Inc.：用于中枢神经系统疾病的干细胞疗法的临床试验。采访 Martin McGlynn。

Regen Med. 2012 Nov;7(6 Suppl):8-11. doi: 10.2217/rme.12.81.

5

HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.HuCNS-SC人神经干细胞在阿尔茨海默病转基因模型中无法分化、形成异位簇且无认知益处。

Stem Cell Reports. 2017 Feb 14;8(2):235-248. doi: 10.1016/j.stemcr.2016.12.019.

6

ReNeuron and StemCells get green light for neural stem cell trials.ReNeuron公司和干细胞公司的神经干细胞试验获得批准。

Nat Biotechnol. 2011 Feb;29(2):95-7. doi: 10.1038/nbt0211-95.

7

Clinical translation of human neural stem cells.人类神经干细胞的临床转化

Stem Cell Res Ther. 2013 Aug 29;4(4):102. doi: 10.1186/scrt313.

8

Stem cell therapy for Alzheimer's disease: hope or hype?用于治疗阿尔茨海默病的干细胞疗法：希望还是炒作？

Lancet Neurol. 2016 Feb;15(2):133-135. doi: 10.1016/S1474-4422(15)00382-8. Epub 2015 Dec 17.

9

Potential of neural stem cell-based therapies for Alzheimer's disease.基于神经干细胞的阿尔茨海默病治疗潜力。

J Neurosci Res. 2015 Sep;93(9):1313-24. doi: 10.1002/jnr.23555. Epub 2015 Jan 19.

10

Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review.针对阿尔茨海默病的靶向小胶质细胞的干细胞疗法：临床前数据综述。

J Neurosci Res. 2017 Dec;95(12):2420-2429. doi: 10.1002/jnr.24066. Epub 2017 Jun 23.

引用本文的文献

1

Cell-Cell Contact Mediates Gene Expression and Fate Choice of Human Neural Stem/Progenitor Cells.细胞间接触介导人类神经干细胞/祖细胞的基因表达和命运选择。

Cells. 2022 May 25;11(11):1741. doi: 10.3390/cells11111741.

2

Regenerative Therapies for Spinal Cord Injury.脊髓损伤的再生治疗。

Tissue Eng Part B Rev. 2019 Dec;25(6):471-491. doi: 10.1089/ten.TEB.2019.0182. Epub 2019 Oct 23.

3

Cellular therapy for traumatic neurological injury.创伤性神经损伤的细胞治疗。

Pediatr Res. 2018 Jan;83(1-2):325-332. doi: 10.1038/pr.2017.253. Epub 2017 Nov 1.

本文引用的文献

1

Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury.用于颈脊髓损伤通路研究的人中枢神经系统来源干细胞的临床前疗效失败

Stem Cell Reports. 2017 Feb 14;8(2):249-263. doi: 10.1016/j.stemcr.2016.12.018.

2

HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.HuCNS-SC人神经干细胞在阿尔茨海默病转基因模型中无法分化、形成异位簇且无认知益处。

Stem Cell Reports. 2017 Feb 14;8(2):235-248. doi: 10.1016/j.stemcr.2016.12.019.

3

Achieving Informed Consent for Cellular Therapies: A Preclinical Translational Research Perspective on Regulations versus a Dose of Reality.实现细胞疗法的知情同意：从临床前转化研究角度看法规与现实情况

J Law Med Ethics. 2016 Sep;44(3):394-401. doi: 10.1177/1073110516667937.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。